Lars Nannestad Jørgensen

Lars Nannestad Jørgensen serves as Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, with clinical affiliations at Bispebjerg Hospital (Bispebjerg Bakke 23) and Rigshospitalet (Blegdamsvej 3) in Copenhagen. His dual appointment bridges surgical practice and academic research within Denmark's public healthcare system, focusing on gastrointestinal malignancies and perioperative care.

His research program centers on translational surgical oncology, particularly colorectal cancer screening optimization through liquid biopsy technologies and fecal immunochemical testing. Key investigations include postoperative monitoring systems for early complication detection, cost-effectiveness analyses of cancer screening programs, and novel biomarker discovery in pancreatic cancer. Recent work explores the intersection of artificial intelligence and medical education, examining large language model applications in surgical research.

Analysis of his 2024-2025 publications reveals strong emphasis on colorectal cancer diagnostics (62.5% of recent work), with significant contributions to perioperative monitoring technology and healthcare economics. Emerging trends include integration of circulating tumor DNA in screening protocols and rigorous evaluation of AI tools for surgical research abstract generation.

His extensive publication record (256 outputs including 223 journal articles) demonstrates substantial collaborative networks across Danish hospitals and international institutions. Social media impact is notable with 18 X (Twitter) mentions for his colorectal cancer cost study and 40 Mendeley readers for his pancreatic cancer biomarker research, indicating significant clinical relevance.